Skip to content

Theralase Technologies Inc. Price, Chart & Factor Analysis

Free Data & Analytics Access
Theralase Technologies Inc. · E.TLT.V · Canada
Use symbol E.TLT.V in our API & Excel add-in to retrieve this data ↓
0.18
(-0.08%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -100%
Trend -100%
Bubble Risk LOW
Realised Volatility (20D) 84.99%

Theralase Technologies Inc. Forecast

Theralase Technologies Inc. short-term momentum is strongly negative (up over 0 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (0 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 85.0% a year, a typical one-standard-deviation range is 0.1541–0.1959 over a week, 0.1321–0.2179 over a month and 0.0263–0.3237 over a year. (Signals as of 22 Nov 2026.)

Theralase Technologies Inc. Price Chart

MacroFinance.ai

Theralase Technologies Inc. Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Theralase Technologies Inc.
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Theralase Technologies Inc.
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Theralase Technologies Inc.
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Theralase Technologies Inc., red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Theralase Technologies Inc.

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Statistical Distribution of Returns

Plus

How Theralase Technologies Inc.’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Theralase Technologies Inc. behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Theralase Technologies Inc. (Canada)

Theralase Technologies Inc. is a listed security in Canada. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on iShares 20+ Year Treasury Bond ETF

Frequently asked questions

What is Theralase Technologies Inc.?
Theralase Technologies Inc. is a listed security in Canada. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns and free historical data.
What is the latest Theralase Technologies Inc. price?
The latest close is 0.175 (22 Nov 2026), -0.08% on the day. The price at the top of the page refreshes during the trading day.
Is Theralase Technologies Inc. in an uptrend?
As of 22 Nov 2026, short-term momentum is strongly negative (0 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly negative (0 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Theralase Technologies Inc.?
20-day realised volatility is 85.0% a year (22 Nov 2026), which implies a typical one-standard-deviation move of about 24.5% over a month and 12.0% over a week.
What factors affect Theralase Technologies Inc.?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Theralase Technologies Inc., grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
How are Theralase Technologies Inc. returns analysed?
The Statistical Distribution of Returns section shows the distribution of Theralase Technologies Inc. daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Theralase Technologies Inc. historical data?
In the Free historical data section of this page: the last 10 years of Theralase Technologies Inc. daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Theralase Technologies Inc. historical data (last 10 years)

Browse or instantly download the last 10 years of Theralase Technologies Inc. daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.TLT.V&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-200.175
2026-11-190.19
2026-11-180.18
2026-11-170.18
2026-11-160.18
2026-11-130.19
2026-11-120.19
2026-11-110.19
2026-11-100.18
2026-11-090.19
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United States, and internationally. The company operates in two segments, Drug Division and Device Division. It engages in the research and development of Rutherrin, an injectable form of Ruvidar for the treatment of glio blastoma multiforme, a form of brain cancer, non-small cell lung cancer, pancreatic cancer, colorectal cancer, and muscle invasive bladder cancer; and Ruvidar, a topical treatment for herpes simplex virus-1 lesions and an extracorporeal treatment for lymphoma, leukemia, and multiple myeloma. The company also researches, develops, manufactures, and distributes Cool Laser Therapy systems to healthcare practitioners for the healing of pain. Theralase Technologies Inc. is based in Toronto, Canada.